ACM
Aquilo Capital Management Portfolio holdings
AUM
$37.1M
This Quarter Return
+2.75%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$425M
AUM Growth
+$425M
(+10%)
Cap. Flow
+$52.5M
Cap. Flow
% of AUM
12.35%
Top 10 Holdings %
Top 10 Hldgs %
93.22%
Holding
17
New
1
Increased
11
Reduced
–
Closed
3
Top Buys
| 1 |
Arvinas
ARVN
|
$29.2M |
| 2 |
Spero Therapeutics
SPRO
|
$13.5M |
| 3 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$13M |
| 4 |
Regenxbio
RGNX
|
$10.2M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$7.52M |
Top Sells
| 1 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$23.6M |
| 2 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
$9.89M |
| 3 |
Galapagos
GLPG
|
$9.81M |
Sector Composition
| 1 | Healthcare | 88.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Spero Therapeutics
SPRO
$115M
| $84M | 15.26% |
4,563,688
+734,479
| +19% | +$13.5M |
|
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $53.6M | 9.74% |
521,673
+73,161
| +16% | +$7.52M |
|
|
DRNA
3
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $49.5M | 8.99% |
2,456,595
+643,203
| +35% | +$13M |
|
4
uniQure
QURE
$920M
| $42.2M | 7.67% |
1,319,513
+162,000
| +14% | +$5.19M |
|
|
5
Regenxbio
RGNX
$464M
| $35.2M | 6.39% |
839,139
+243,695
| +41% | +$10.2M |
|
6
Arrowhead Research
ARWR
$3.5B
| $33M | 5.99% |
527,926
+95,000
| +22% | +$5.93M |
|
7
4D Molecular Therapeutics
FDMT
$285M
| $29.7M | 5.39% |
1,099,944
+154,562
| +16% | +$4.17M |
|
|
8
Arvinas
ARVN
$572M
| $29.2M | 5.29% |
+354,711
| New | +$29.2M |
|
9
Dianthus Therapeutics
DNTH
$770M
| $23M | 4.17% |
3,155,082
+467,899
| +17% | +$3.41M |
|
|
AMYT
10
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $16.7M | 3.04% |
1,390,000
+250,000
| +22% | +$3.01M |
|
|
PVLA
11
Palvella Therapeutics, Inc. Common Stock
PVLA
$577M
| $16.5M | 3% |
3,196,527
| – | – |
|
12
argenx
ARGX
$42.8B
| $6.7M | 1.22% |
22,200
+1,000
| +5% | +$302K |
|
13
Genmab
GMAB
$15.9B
| $5.57M | 1.01% |
127,500
+7,500
| +6% | +$328K |
|
|
14
Galapagos
GLPG
$2.05B
| – | – |
-142,340
| Closed | -$9.81M |
|
15
SPDR S&P Biotech ETF
XBI
$5.23B
| – | – |
0
| – | – |
|
|
NGM
16
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| – | – |
-1,194,237
| Closed | -$23.6M |
|
|
HARP
17
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| – | – |
-712,674
| Closed | -$9.89M |
|